Rankings
▼
Calendar
IMA Q2 2024 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena
IMA
ImageneBio Inc
$67M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$400,000
Operating Income
-$16M
Net Income
-$14M
EPS (Diluted)
$-0.28
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$157M
Total Liabilities
$15M
Stockholders' Equity
$143M
Cash & Equivalents
$44M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$2M
-100.0%
Gross Profit
-$400,000
-$12M
+96.7%
Operating Income
-$16M
-$18M
+14.4%
Net Income
-$14M
-$17M
+19.8%
← FY 2024
All Quarters
Q3 2024 →